Global Cbd Patch Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 324,986.93 Million |
 Market Size (Forecast Year) |
USD 624,171.30 Million |
 CAGR |
% |
| Major Markets Players |
>全球 CBD 贴片市场，按产品（储层、基质、粘合剂药物层）、种类（印度大麻、杂交大麻、苜蓿大麻）、包装（两到五个贴片、单个贴片、五个以上贴片）、剂量（30 毫克以下、30-40 毫克、40-50 毫克、50 毫克以上）、衍生物（大麻二酚 (CBD)、四氢大麻酚 (THC)、其他）、应用（慢性疼痛、焦虑、关节炎、情绪提升、神经性疼痛、其他）、来源类型（天然、合成）、最终用户（家庭护理环境、研发中心、医院、诊所、康复中心、其他）、分销渠道（药房和药房、线上、传统商店）- 行业趋势和预测到 2031 年。
CBD 贴片市场分析和规模
对于不想通过传统方式（如油、胶囊或食物）服用 CBD 的用户来说，CBD 贴剂非常方便。贴剂提供了一种谨慎而简单的方法，将 CBD 融入日常生活。透皮贴剂可缓慢而持续地释放 CBD，与其他服用方式相比，效果更持久。这对于寻求持续和长期 CBD 体验的个人来说可能很有益。与涉及消化系统的口服不同，透皮贴剂绕过了消化道。这对于胃部敏感的人或想要避免口服摄入带来的变化的人来说是有利的。
Data Bridge Market Research 分析，CBD 贴片市场规模在 2023 年为 3249.8693 亿美元，到 2031 年可能达到 6241.713 亿美元，预计在预测期内复合年增长率为 8.5%。由于对 CBD 贴片的需求不断增长，“家庭护理环境”在 CBD 贴片市场的最终用户细分市场中占据主导地位。
除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察之外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
CBD 贴片市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按产品（储层、基质、粘合剂药物层）、种类（印度大麻、杂交大麻、苜蓿大麻）、包装（2 至 5 个贴片、单个贴片、5 个贴片以上）、剂量（30 毫克以下、30-40 毫克、40-50 毫克、50 毫克以上）、衍生物（大麻二酚 (CBD)、四氢大麻酚 (THC)、其他）、应用（慢性疼痛、焦虑、关节炎、情绪提升、神经性疼痛、其他）、来源类型（天然、合成）、最终用户（家庭护理环境、研发中心、医院、诊所、康复中心、其他）、分销渠道（药房和药房、线上、传统商店） |
|
Countries Covered |
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Sweden, Denmark, Poland, Rest of Europe, Japan, China, Australia, New Zealand, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, Ethiopia, Rest of the Middle East and Africa |
|
Market Players Covered |
Papa and Barkley (U.S.), Pure Ratios (U.S.), Charlotte’s Web (U.S.), Bioactive Solutions, Inc.(U.S.), La Mend Inc.(U.S.), Always Pure Organics Ltd (UK), Envy CBD (U.S.), GoGreen Hemp (U.S.), Harmony (Spain), Healist Naturals (U.S.), HempBombs.com (U.S.), Isodiol International Inc. (Canada), Kangdi Overseas Business Co., Ltd.(China), Manna Molecular (U.S.), Mary’s Medicinal (U.S.), Natures Script (U.S.), Nutrae, LLC.(U.S.), PureKana, SAVAN (U.S.), Shenzhen Ruiyan Technology Co., Ltd (China), Snowden Ltd.(U.S.), Social CBD (U.S.), Upstate Elevator Supply Co.(U.S.) |
|
Market Opportunities |
|
Market Definition
CBD patches offer a convenient and discreet method of CBD administration. Users can apply the patch to their skin, and it remains in place, allowing for continuous and controlled release of CBD without the need for repeated dosing or oral ingestion.
Global CBD Patch Market Dynamics
Drivers
- Rising Incidence of Chronic Diseases
The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders necessitates the development and administration of sterile injectable drugs. CBD patch play a crucial role in the treatment and management of chronic conditions. Pharmaceutical companies have an opportunity to focus on developing innovative injectable therapies for these diseases, addressing unmet medical needs.
- Advancements in Drug Delivery Technologies
Ongoing advancements in drug delivery technologies, such as prefilled syringes and autoinjectors, provide opportunities to enhance the administration and convenience of CBD patch. Companies can invest in research and development to improve drug delivery systems, making injections more patient-friendly and improving adherence to treatment regimens. Enhanced delivery technologies may also contribute to the development of self-administered injectables.
Opportunity
- Focus on Rare Diseases
The orphan drug market, including sterile injectables for rare diseases, represents an opportunity for companies to address unmet medical needs in niche patient populations. Companies can prioritize research and development efforts to create injectable therapies for rare diseases, benefiting from regulatory incentives and potentially establishing a strong market presence in specific therapeutic areas.
Restraint/Challenge
- High Development Cost
The research, development, and manufacturing of CBD patch involve significant costs, including expenses related to clinical trials, regulatory compliance, and adherence to stringent quality standards. The high upfront costs can be a barrier, particularly for smaller pharmaceutical companies. These financial challenges may limit the number of companies entering the market and potentially slow down the development of new injectable drugs.
Recent Development
- In May 2020, AbbVie Inc. acquired Allergan, a global company focused on manufacturing products targeting neuroscience, urology among other medical fields. This acquisition allowed the company to enhance its therapeutic categories and strengthen the company's financial values, which ultimately accelerated the company's research and developmental activities
Global CBD Patch Market Scope
The CBD patch market is segmented on the basis of product, application, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Reservoir
- Matrix
- Layer Drug-In-Adhesive
Species
- Cannabis Indica,
- Hybrid
- Sativa
Packaging
- Two to Five Patches
- Single Patch
- More Than Five Patch
Dosage
- Below 30 mg, 30-40 mg
- 40-50 mg
- Above 50 mg
Derivatives
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)
- Others
Application
- Chronic Pain
- Anxiety
- Arthritis
- Elevate Mood
- Neurological Pain
- Others
Source Type
- Natural
- Synthetic
End User
- Homecare Settin
- Research and Development Centers
- Hospital
- Clinics
- Rehab Centers
- Others
Distribution Channel
- Dispensaries & Pharmacies
- Online
- Conventional Stores
Global CBD Patch Market Regional Analysis/Insights
The CBD patch market is analyzed and market size insights and trends are provided by country, product, application, end users, and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Sweden, Denmark, Poland, rest of Europe, Japan, China, Australia, New Zealand, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, Ethiopia and rest of the Middle East and Africa.
North America is expected to dominate the market due to the presence of advanced healthcare infrastructure.
Asia-Pacific is the fastest-growing region in the market due to the rising prevalence of infectious diseases.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
CBD 贴片市场还为您提供了详细的市场分析，包括每个国家在资本设备医疗保健支出的增长情况、CBD 贴片市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管场景的变化及其对 CBD 贴片市场的影响。
竞争格局和 CBD 贴片市场份额分析
CBD 贴片市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对 CBD 贴片市场的关注有关。
CBD 贴片市场的一些主要参与者包括：
- 吉利德科学公司（美国）
- BIOCRYST PHARMACEUTICALS, INC.（美国）
- 阿斯利康（英国）
- Genentech, Inc.（F. Hoffmann-La Roche Ltd. 的子公司）（美国）
- 默克夏普和多姆公司（默克公司的子公司）（美国）
- Hikma Pharmaceuticals PLC（英国）
- AbbVie Inc.（美国）
- American Regent, Inc.（第一三共集团旗下公司）（美国）
- 安进公司 (美国)
- 百时美施贵宝公司（美国）
- Teligent (美国)
- 卫材株式会社（日本）
- Teva Pharmaceutical Industries Ltd.（以色列）
- Neuren Pharmaceuticals（澳大利亚）
- Noxopharm（澳大利亚）
- Amomed Pharma GmbH（奥地利）
- 赛诺菲（法国）
- Exelixis, Inc.（美国）
- Fresenius Kabi USA（Fresenius SE & Co. KGaA 的子公司）（美国）
- 辉瑞公司（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
